Table 4.

The effects of hyperin on cholesterol metabolism in liver cells (mRNA analysis).

Treatment	LDL-R	HMG-CoAR	CYP7A1	ACAT2
No hyperin	1	1	1	1
Hyperin: low dose	1.64 ± 0.27*	2.18 ± 0.19**	1.21 ± 0.18*	1.03 ± 0.21
Hyperin: medium dose	2.82 ± 0.36**	3.29 ± 0.31**	1.57 ± 0.22**	0.65 ± 0.36**
Hyperin: high dose	2.66 ± 0.24**	2.87 ± 0.25**	1.06 ± 0.19	0.61 ± 0.29**
Atorvastatin	5.82 ± 0.27**	6.48 ± 0.29**	1.29 ± 0.45**	0.49 ± 0.38**

Note: comparison with no-drug control group, *P < 0.05, **P < 0.01.